Newsroom

Press release
25 February 2021

Renewed funding paves way for implementation of Consortium’s access program

Read more
Press release
22 May 2018

Renowned African Research Institutes Join Pediatric Praziquantel Consortium

Complementary experience offered by the Kenya Medical Research Institute (KEMRI) and the Université Félix Houphouët-Boigny (UFHB) in conducting clinical...

Read more
Press release
12 October 2016

Schistosomiasis Control Initiative and Pediatric Praziquantel Consortium join forces in the fight against schistosomiasis

Goal is to make a child-friendly treatment for schistosomiasis accessible to children under six years of age in endemic countries

Read more
Press release
29 May 2015

Pediatric Praziquantel Consortium Awarded USD4.9 Million Grant from Global Health Innovative Technology Fund

The second research grant from GHIT provides further support for the Phase II development of a pediatric formulation to combat schistosomiasis in pre-school...

Read more
Press release
28 March 2014

Pediatric Praziquantel Consortium awarded US$1.86 million GHIT grant

The Pediatric Praziquantel Consortium, launched in 2012 as an international non-profit public-private partnership, has announced that it has been awarded a...

Read more
Press release
25 March 2014

Pediatric Praziquantel Consortium expands into Brazil

Goal is to make treatment for schistosomiasis accessible to children under six years of age in endemic countries.

Read more
Press release
22 August 2013

International partnership receives funding to develop a drug product to fight schistosomiasis (bilharzia) in children

An international public-private partnership (PPP) was launched in July last year to develop a new pediatric formulation to combat schistosomiasis - commonly...

Read more
Press release
02 July 2012

New public-private partnership to develop a treatment for schistosomiasis-infected preschool children

A newly established international public-private partnership (PPP) between TI Pharma, Merck KGaA (Darmstadt, Germany), Astellas Pharma Inc. and the Swiss...

Read more